Skip to main content
OpenTrials

Clinical trial condition

Simpson-Golabi-Behmel syndrome

Explore clinical trials studying Simpson-Golabi-Behmel syndrome. Study availability and eligibility vary by location and protocol.

12 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Simpson-Golabi-Behmel syndrome trial results

Recruiting

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

NCT06795022

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site St Louis, Missouri, United States
View all 21 locations
View Trial Details
Recruiting

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

NCT06427941

Conditions
Adenocarcinoma, Alpha-fetoprotein (AFP)-Producing Gastric Cancer, Carcinoma, +14 more
Locations
  • City of Hope Phoenix Cancer Center Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Chicago Cancer Center Zion, Illinois, United States
  • Memorial Sloan Kettering Cancer Center Mskcc New York, United States
View all 47 locations
View Trial Details
Recruiting

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

NCT04928677

Conditions
Disease Attributes, Hepatoblastoma, Neoplasms, +8 more
Locations
  • Children's Hospital of Los Angeles (Data Collection Only) Los Angeles, California, United States
  • Children's Healthcare of Atlanta (Data Collection Only) Atlanta, Georgia, United States
  • Dana Farber Cancer Institute (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC

NCT06478693

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • St Vincent's Hospital Sydney, New South Wales, Australia
  • Integrated Clinical Oncology Network (ICON) Pty Ltd Woolloongabba, Queensland, Australia
  • The Alfred Hospital Melbourne, Victoria, Australia
  • Linear Clinical Research Murdoch, Western Australia, Australia
View Trial Details

Related conditions